{"id":"W4403153858","doi":"10.1210/jendso/bvae163.1587","title":"5092 Effect of Fezolinetant Treatment on Patient-Reported Outcomes: Data from Phase 3b study (DAYLIGHT) for Moderate-To-Severe Vasomotor Symptoms Associated with Menopause in Women Considered Unsuitable for Hormone Therapy","year":2024,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Pharma; Shionogi; Novo Nordisk; Gedeon Richter; Astellas Foundation for Research on Metabolic Disorders; Bayer HealthCare; Mylan","keywords":"Vasomotor; Menopause; Medicine; Hormone therapy; Hormone; Internal medicine; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001505472,0.0004370989,0.001211975,0.000280832,0.0002521069,0.0005767225,0.0004711991,0.0008041369,0.007162551],"category_scores_gemma":[0.001813191,0.0001779373,0.001833959,0.0002635583,0.0003055126,0.0003455499,0.0002261211,0.001755282,0.0009446663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000332041,"about_ca_system_score_gemma":0.000456198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001004782,"about_ca_topic_score_gemma":0.002917208,"domain_scores_codex":[0.9994117,0.0003418321,0.00004481818,0.00006695106,0.00007674323,0.00005799583],"domain_scores_gemma":[0.9988721,0.0004093777,0.0002898248,0.00009210099,0.0001148567,0.0002216185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7169352,0.01068205,0.01418699,0.003197324,0.004266705,0.0001331119,0.0001406375,0.0007361119,0.01219027,0.000205367,0.02044082,0.2168854],"study_design_scores_gemma":[0.6224642,0.2116353,0.1470081,0.0004951007,0.002896402,0.0002659726,0.00009728841,0.001395038,0.001970229,0.0002918821,0.01141222,0.0000681415],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9387373,0.02996823,0.0005859223,0.002314548,0.0005541708,0.00211553,0.01473403,0.0001681666,0.0108221],"genre_scores_gemma":[0.9727154,0.006942295,0.001464121,0.002208191,0.0003949748,0.001461778,0.009329743,0.00004090305,0.00544266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007162551,"threshold_uncertainty_score":0.02396107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05893030198580484,"score_gpt":0.377105387663658,"score_spread":0.3181750856778532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}